Results of recent studies [16, 30], suggest an independent association of the presence of TET2 or DNMT3A mutations with ATE, as well as ASXL1, NRAS, and TP53 mutations with VTE in patients in the general MPN cohort. Here, ASXL1 is linked to myeloproliferative neoplasm.